LAB vs PACB

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 14, 2026

LAB

56.3
AI Score
VS
LAB Wins

PACB

39.9
AI Score

Investment Advisor Scores

LAB

56score
Recommendation
HOLD

PACB

40score
Recommendation
SELL

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric LAB PACB Winner
Revenue 41.25M 76.19M PACB
Net Income 100.31M -53.02M LAB
Gross Margin 53.0% 33.4% LAB
Net Margin 243.2% -69.6% LAB
Operating Income -37.88M -52.97M LAB
ROE 18.6% 159.6% PACB
ROA 16.0% -7.1% LAB
Total Assets 627.22M 751.85M PACB
Cash 270.03M 61.00M LAB
Current Ratio 9.10 4.92 LAB
Free Cash Flow -57.82M -84.87M LAB

Relative Price Performance (Last 90 Days)

LAB 1M: -13.1% · 3M: -23.9% PACB 1M: +17.1% · 3M: -3.7%

Current Technical Phase

LAB

Markdown
Sell / avoid

Price below a falling SMA50 (slope -9.4%), weak momentum, RSI 45

RSI (14): 44.5 · Price: $0.69

PACB

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 48

RSI (14): 47.6 · Price: $1.30

Fundamentals Snapshot

Metric LAB PACB
Market Cap
Forward P/E -4.3 -3.2
Trailing P/E
Revenue (TTM)
Revenue Growth -0.1% 0.0%
Gross Margin 0.5% 0.3%
Operating Margin -0.4% -1.1%
EPS -0.13 -0.41
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, LAB is currently the stronger investment candidate, winning 8 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.